E-LIB Suche - Ergebnisse für: Schaller, Teilo H.

1

Case Studies for Overcoming Challenges in Using Big Data in..:

Sweeney, Shawn M. ; Hamadeh, Hisham K. ; Abrams, Natalie...
Cancer Research. 83 (2023) 8 - p. 1183-1190 , 2023

2

Consensus disease definitions for neurologic immune-related..:

Guidon, Amanda C ; Burton, Leeann B ; Chwalisz, Bart K...
Journal for ImmunoTherapy of Cancer. 9 (2021) 7 - p. e002890 , 2021

Link: https://doi.org/10.1136/..

3

Immune-related adverse events associated with immune checkp..:

Reynolds, Kerry L ; Arora, Shaily ; Elayavilli, Ravikumar Komandur...
Journal for ImmunoTherapy of Cancer. 9 (2021) 7 - p. e002896 , 2021

Link: https://doi.org/10.1136/..

4

First in human dose calculation of a single-chain bispecifi..:

Schaller, Teilo H ; Snyder, David J ; Spasojevic, Ivan...
Journal for ImmunoTherapy of Cancer. 8 (2020) 1 - p. e000213 , 2020

Link: https://doi.org/10.1136/..

5

GLP toxicology study of a fully-human T cell redirecting CD..:

Gedeon, Patrick C. ; Streicker, Michael A. ; Schaller, Teilo H....
PLOS ONE. 15 (2020) 7 - p. e0236374 , 2020

Link: https://doi.org/10.1371/..

6

Pharmacokinetic Analysis of a Novel Human EGFRvIII:CD3 Bisp..:

Schaller, Teilo H. ; Foster, Matthew W. ; Thompson, J. Will...
Journal of Proteome Research. 18 (2019) 8 - p. 3032-3041 , 2019

Link: https://doi.org/10.1021/..

7

IMST-45. A FULLY-HUMAN EGFRvIII-TARGETED BISPECIFIC ANTIBOD..:

Gedeon, Patrick C. ; Schaller, Teilo H. ; Suryadevara, Carter M....
Neuro-Oncology. 18 (2016) suppl_6 - p. vi96-vi96 , 2016

Link: https://doi.org/10.1093/..

8

Challenges to Using Big Data in Cancer:

Sweeney, Shawn M. ; Hamadeh, Hisham K. ; Abrams, Natalie...
Cancer Research. 83 (2023) 8 - p. 1175-1182 , 2023

Link: https://doi.org/10.1158/..

9

Consensus disease definitions for neurologic immune-related..:

Andrew L Mammen ; Jarushka Naidoo ; Divyanshu Dubey...
https://jitc.bmj.com/content/9/7/e002890.full. , 2021

Link: https://doi.org/10.1136/..

10

GLP toxicology study of a fully-human T cell redirecting CD..:

Patrick C Gedeon ; Michael A Streicker ; Teilo H Schaller...
https://doi.org/10.1371/journal.pone.0236374. , 2020

Link: https://doi.org/10.1371/..

11

Advances and challenges: dendritic cell vaccination strateg..:

Teilo H. Schaller ; John H. Sampson
http://dx.doi.org/10.1080/14760584.2016.1218762. , 2017

Link: https://doi.org/10.1080/..

12

IMMU-05. A PHASE I STUDY IN PROGRESS OF HEGFRVIII-CD3 BI-SC..:

Singh, Kirit ; Hotchkiss, Kelly ; Gedeon, Patrick...
Neuro-Oncology Advances. 3 (2021) Supplement_4 - p. iv5-iv5 , 2021

Link: https://doi.org/10.1093/..

13

EXTH-82. T CELL HITCHHIKING AS A MECHANISM OF DRUG DELIVERY..:

Singh, Kirit ; Gedeon, Patrick ; Schaller, Teilo...
Neuro-Oncology. 23 (2021) Supplement_6 - p. vi182-vi182 , 2021

Link: https://doi.org/10.1093/..

14

EXTH-09. FIRST-IN-HUMAN DOSING CONSIDERATIONS OF A BISPECIF..:

Schaller, Teilo ; Foster, Matthew ; Spasojevic, Ivan...
Neuro-Oncology. 21 (2019) Supplement_6 - p. vi84-vi84 , 2019

Link: https://doi.org/10.1093/..

15

IMMU-23. ANTIGEN-SPECIFIC EFFECTOR MEMORY CD4+ T CELLS AND ..:

Batich, Kristen ; Sanchez-Perez, Luis ; Schaller, Teilo...
Neuro-Oncology. 20 (2018) suppl_6 - p. vi126-vi126 , 2018

Link: https://doi.org/10.1093/..